Cargando…
Caveolin-1 Is Essential for the Improvement of Insulin Sensitivity through AKT Activation during Glargine Treatment on Diabetic Mice
Insulin treatment was confirmed to reduce insulin resistance, but the underlying mechanism remains unknown. Caveolin-1 (Cav-1) is a functional protein of the membrane lipid rafts, known as caveolae, and is widely expressed in mammalian adipose tissue. There is increasing evidence that show the invol...
Autores principales: | Peng, Hangya, Mu, Panwei, Li, Haicheng, Lin, Shuo, Lin, Chuwen, Lin, Keyi, Liu, Kunying, Zeng, Wen, Zeng, Longyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670926/ https://www.ncbi.nlm.nih.gov/pubmed/34917687 http://dx.doi.org/10.1155/2021/9943344 |
Ejemplares similares
-
A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes
por: Lin, Shuo, et al.
Publicado: (2018) -
Utility of Neck Circumference for Identifying Metabolic Syndrome by Different Definitions in Chinese Subjects over 50 Years Old: A Community-Based Study
por: Lin, Shuo, et al.
Publicado: (2018) -
Insulin glargine overdose
por: Doğan, Fatma Sarı, et al.
Publicado: (2012) -
Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus
por: Linnebjerg, Helle, et al.
Publicado: (2016) -
Insulin glargine and the risk of cancer
por: Ahmed, FA
Publicado: (2010)